Microbiome Sequencing Services Market

Microbiome Sequencing Services Market by Service (Sample Preparation, Sequencing, Library Preparation), Type (Amplicon Sequencing, Whole Genome Sequencing), Technology (Sequencing by Synthesis, Nanopore Sequencing), End User - Global Forecast to 2028

Report Code: BT 5306 May, 2023, by marketsandmarkets.com

The global microbiome sequencing services market in terms of revenue was estimated to be worth $284 million in 2023 and is poised to reach $555 million by 2028, growing at a CAGR of 14.3% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Rising focus on human microbiome therapeutics development has emerged as one of the key driving factors for market growth. The increasing focus on human microbiome therapeutics development is driving therapeutics manufacturers to opt for sequencing, sample preparation, and data analysis services. This is further propelled by the need for a deeper understanding of the microbiome, including its composition, function, and interaction with the host to develop microbiome-based therapeutics. Microbiome sequencing plays a critical role in providing this understanding by allowing for the identification and characterization of the microorganisms that make up the microbiome.

Attractive Opportunities in the Microbiome Sequencing Services Market

Microbiome Sequencing Services Market

To know about the assumptions considered for the study, Request for Free Sample Report

Microbiome Sequencing Services Market

Microbiome Sequencing Services Market Dynamics

DRIVER: High cost of advanced infrastructure for sequencing

The field of microbiome sequencing requires sophisticated and expensive equipment, such as next-generation sequencing (NGS) platforms, bioinformatics tools, and data storage and analysis capabilities. Setting up and maintaining such infrastructure can be cost-prohibitive for many research and academic institutes, pharmaceutical and biotechnology companies, and other end users. Outsourcing microbiome sequencing to specialized service providers allows professionals to access advanced infrastructure and expertise without the need for substantial upfront investments. These service providers typically have state-of-the-art facilities and experienced personnel who are skilled in performing microbiome sequencing using the latest technologies and methodologies. Through outsourcing, professionals can leverage the capabilities of these specialized facilities without the burden of capital expenditures, operational costs, and maintenance expenses associated with in-house infrastructure.

RESTRAINT: Dearth of skilled personnel

The shortage of skilled personnel with expertise in sequencing and data analysis is a significant challenge in the field of microbiome sequencing. Microbiome research involves complex methodologies, including sample collection, DNA extraction, library preparation, sequencing, and data analysis. The proper execution of these steps requires specialized knowledge and technical expertise. However, the field of microbiome sequencing is relatively new and evolving rapidly, with a shortage of skilled personnel with the necessary expertise. Training and developing skilled personnel in microbiome sequencing can be time-consuming and resource-intensive, and there may be a lag in keeping up with the latest advancements in sequencing technologies and data analysis methods.

OPPORTUNITY: Expanding applications of microbiome sequencing in therapeutics development

Oral microbiome sequencing can provide insights into the microbial etiology of oral health conditions, identify key pathogenic species or functional genes associated with oral diseases, and reveal potential therapeutic targets for intervention. This knowledge can be used to develop novel strategies for oral health management, including probiotics, antimicrobial treatments, and personalized oral care regimens tailored to an individual's oral microbiome.

CHALLENGE: Issues related to sample preparation/isolation of microbes for sequencing

Despite the success of using metagenomic sequence data to guide the isolation and cultivation of microbes, there are still challenges and limitations that need to be addressed for more widespread success. Anaerobic microbes may also pose technical challenges for some targeted isolation methods due to limitations with cell sorters. Determining suitable growth media and physicochemical conditions for target organisms based solely on genome sequences can be challenging, as natural environment compositions are often unknown. Contamination can also be a significant challenge in microbiome research, as it can introduce non-target microbial DNA from external sources during sample collection, processing, and sequencing. Contamination can arise from reagents, equipment, and environmental sources, leading to false-positive or false-negative results. Proper controls, including negative controls and rigorous contamination prevention measures, should be implemented to minimize contamination and ensure accurate and reliable sequencing results.

Microbiome Sequencing Services: Market Ecosystem

Microbiome sequencing services start with outsourcing of study design, wherein the service provider helps in the implementation and validation of the hypothesis and the variables of interest in a sequencing project. Different variables in the aspect of study design include the number of samples required, apt sequencing technology to be used, and the requirement of follow-up studies. Service providers have expertise with respect to the collection, storage, and transport options optimized for this workflow. NGS instruments are predominantly used for the sequencing of DNA and RNA samples. Shotgun metagenomics sequencing is offered by a majority of sequencing service providers, even for deep-sequenced samples. DNA library preparation is verified for quality and yield. Genomic DNA is fragmented at specific sizes suitable for the purification/separation of desired proteins and nucleic acids.

Prominent players in this market include Charles River Laboratories (US), Eurofins Scientific (France), BGI (China), CosmosID (US), Microba (Australia), QIAGEN (Germany), Microbiome Insights (Canada), BaseClear (Netherlands), CD Genomics (US), Zymo Research (US), OraSure Technologies (US), MR DNA (US), Eremid Genomic Services (US), Clinical-Microbiomics A/S (Denmark), Novogene Co., Ltd. (China), EzBiome (US), Boster Biological Technology (US), Zifo (India), omics2view.consulting GbR (Germany), and Macrogen, Inc. (South Korea).

Ecosystem Analysis: Microbiome Sequencing Services Market

Microbiome Sequencing Services Market Ecosystem

Source: Annual Reports, SEC Filings, Investor Presentations, Expert Interviews, and MarketsandMarkets Analysis

Based on service, sequencing and library preparation services segment accounted for the largest share of the Microbiome Sequencing Services Market in 2022

Based on service, the market is segmented into sample preparation services, sequencing and library preparation services, and data analysis services. The sequencing and library preparation services segment accounted for the largest share of the market whereas sample preparation services segment accounted for the second-largest share in 2022. Sample preparation segment includes services that are applied for the collection, storage, and processing of samples subjected to microbiome sequencing. It is imperative to ensure that microbiome analysis is reproducible. Reproducibility is affected by several factors, such as sample size, storage methods, and collection methods.

Based on type, amplicon sequencing segment accounted for the largest share of the Microbiome Sequencing Services Market in 2022

Based on type, the global market is segmented into amplicon sequencing, whole-genome sequencing, shotgun sequencing, and other types. Other types of sequencing include metagenomic sequencing, de novo sequencing, and metatranscriptomic sequencing. High accuracy of 16S amplicon sequencing is the key contributor to the dominance of amplicon sequencing segment. Additionally, the demand for targeted sequencing is anticipated to increase in metagenomic research activities. The targeted amplicon sequencing method involves sequencing a phylogenetically informative marker to identify organisms in community samples.

Based on technology, nanopore sequencing segment of the global Microbiome Sequencing Services Market is expected to grow with a highest CAGR throughout the forecast period

Based on technology, the global market is segmented into sequencing by synthesis (SBS), sequencing by ligation (SBL), nanopore sequencing, and other technologies. Introduced by Oxford Nanopore Technologies, nanopore sequencing technology (which is considered the fourth generation of sequencing) has emerged as a competitive, portable technology. The technology works through the detection of unique electrical signals of different molecules as they pass across the nanopore with a semiconductor-based electronic detection system. This technology makes for a high throughput, cost-effective sequencing solution.

The North American market is projected to contribute the largest share for the microbiome sequencing services market.

The global market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America is the largest regional market for microbiome sequencing services. US has emerged as the key revenue contributor to this region. The US market is a rapidly growing and dynamic market that is driven by several factors. One of the key drivers for market growth in the US is the increasing awareness and understanding of the role of the microbiome in human health. Research has shown that microorganisms residing in and on the human body play a crucial role in various physiological processes, including digestion, immunity, and metabolism. The increasing focus on gaining a deep understanding of this has driven the demand for microbiome sequencing services to study the composition and function of the microbiome.

Microbiome Sequencing Services Market by Region

To know about the assumptions considered for the study, download the pdf brochure

The global microbiome sequencing services market is a fragmented market, with Charles River Laboratories (US), Eurofins Scientific (France), and BGI (China) emerging as the top 3 players of the global market. Players such as CosmosID (US), Microba (Australia), QIAGEN (Germany), Microbiome Insights (Canada), BaseClear (Netherlands), CD Genomics (US), Zymo Research (US), OraSure Technologies (US), MR DNA (US), Eremid Genomic Services (US), Clinical-Microbiomics A/S (Denmark), Novogene Co., Ltd. (China), EzBiome (US), Boster Biological Technology (US), Zifo (India), omics2view.consulting GbR (Germany), and Macrogen, Inc. (South Korea) are some of the prominent players in the market.

Microbiome Sequencing Services Market Report Scope

Report Metric 

Details 

Market Revenue in 2023

$284 million

Projected Revenue by 2028

$555 million

Revenue Rate

Poised to Grow at a CAGR of 14.3%

Market Driver

High cost of advanced infrastructure for sequencing

Market Opportunity

Expanding applications of microbiome sequencing in therapeutics development

This research report categorizes the microbiome sequencing services market to forecast revenue and analyze trends in each of the following submarkets:

By Service

  • Sample Preparation
  • Sequencing and Library Preparation
  • Data Analysis

By Type

  • Amplicon Sequencing
  • Whole-genome Sequencing
  • Shotgun Sequencing
  • Other Types

By Technology

  • Sequencing by Synthesis (SBS)
  • Sequencing by Ligation (SBL)
  • Nanopore Sequencing
  • Other Technologies

By End User

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Other End Users

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • RoE
  • Asia Pacific
    • China
    • India
    • Japan
    • RoAPAC
  • Latin America
  • Middle East & Africa

Recent Developments

  • In March 2023, Microba launched a new human gut microbiome testing service for comprehensive gastrointestinal testing solutions. The solutions are accessible to healthcare professionals in Australia through a different brand name, Co-Biome.
  • In February 2023, Locus Biosciences announced a long-term partnership with CosmosID to gain the support of the latter for clinical trial studies. CosmosID’s support for microbiome analysis is expected to assist Locus Biosciences in strengthening its precision therapeutics platform.
  • In March 2022, Diversigen announced the launch of a new service, metatranscriptomic sequencing and analysis of the gut microbiome. This service will assist research professionals in understanding gene expression while gaining insights into both function and mechanism of microbiomes in samples.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 29)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE 
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED
    1.4 CURRENCY 
    1.5 LIMITATIONS 
    1.6 STAKEHOLDERS 
    1.7 SUMMARY OF CHANGES 
           1.7.1 RECESSION IMPACT
 
2 RESEARCH METHODOLOGY (Page No. - 34)
    2.1 RESEARCH DATA 
          FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
                    FIGURE 2 MICROBIOME SEQUENCING SERVICES MARKET: BREAKDOWN OF PRIMARIES
    2.2 MARKET ESTIMATION METHODOLOGY 
          FIGURE 3 MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2022
          FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022
          FIGURE 5 ILLUSTRATIVE EXAMPLE OF COMPANY REVENUE ANALYSIS, 2022
           2.2.1 INSIGHTS FROM PRIMARY EXPERTS
                    FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
    2.3 MARKET GROWTH RATE PROJECTIONS 
          FIGURE 7 MARKET (SUPPLY-SIDE): CAGR PROJECTIONS
          FIGURE 8 MARKET: GROWTH ANALYSIS OF DEMAND-SIDE DRIVERS
    2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 
          FIGURE 9 DATA TRIANGULATION METHODOLOGY
    2.5 RESEARCH ASSUMPTIONS 
    2.6 RISK ANALYSIS 
    2.7 IMPACT OF RECESSION ON MARKET 
          TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH)
          TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
          TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)
 
3 EXECUTIVE SUMMARY (Page No. - 46)
    FIGURE 10 MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2023 VS. 2028 (USD MILLION)
    FIGURE 11 MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
    FIGURE 12 MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
    FIGURE 13 MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    FIGURE 14 GEOGRAPHICAL SNAPSHOT OF MARKET
 
4 PREMIUM INSIGHTS (Page No. - 50)
    4.1 MICROBIOME SEQUENCING SERVICES MARKET OVERVIEW 
          FIGURE 15 GROWING FOCUS ON HUMAN MICROBIOME THERAPEUTICS DEVELOPMENT TO DRIVE MARKET
    4.2 NORTH AMERICA: MARKET, BY SERVICE AND COUNTRY (2023) 
          FIGURE 16 SEQUENCING AND LIBRARY PREPARATION SERVICES TO ACCOUNT FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2023
    4.3 NORTH AMERICA: MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 
          FIGURE 17 SHOTGUN SEQUENCING SEGMENT TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 52)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 18 MICROBIOME SEQUENCING SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
          TABLE 4 MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Increasing demand for metagenomic sequencing
                    5.2.1.2 Growing focus on human microbiome therapeutics development
                                FIGURE 19 ROLE OF MICROBIOME SEQUENCING IN THERAPEUTICS DEVELOPMENT
                    5.2.1.3 High cost of advanced infrastructure for sequencing
                                TABLE 5 AVERAGE SELLING PRICE OF NGS SYSTEMS, BY KEY PLAYER (2021)
           5.2.2 RESTRAINTS
                    5.2.2.1 Dearth of skilled personnel
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Expanding applications of microbiome sequencing in therapeutics development
           5.2.4 CHALLENGES
                    5.2.4.1 Issues related to sample preparation/isolation of microbes for sequencing
    5.3 TECHNOLOGY ANALYSIS 
    5.4 TRENDS AND DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
          FIGURE 20 REVENUE SHIFT AND NEW REVENUE POCKETS FOR MICROBIOME SEQUENCING SERVICE PROVIDERS
    5.5 VALUE CHAIN ANALYSIS 
          FIGURE 21 VALUE CHAIN ANALYSIS OF MARKET
    5.6 ECOSYSTEM MARKET MAP 
          FIGURE 22 ECOSYSTEM OF MARKET
    5.7 PORTER’S FIVE FORCES ANALYSIS 
          TABLE 6 MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.7.1 THREAT OF NEW ENTRANTS
           5.7.2 THREAT OF SUBSTITUTES
           5.7.3 BARGAINING POWER OF SUPPLIERS
           5.7.4 BARGAINING POWER OF BUYERS
           5.7.5 INTENSITY OF COMPETITIVE RIVALRY
    5.8 REGULATORY ANALYSIS 
           5.8.1 NORTH AMERICA
                    5.8.1.1 US
                                TABLE 7 US FDA: MEDICAL DEVICE CLASSIFICATION
                                TABLE 8 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
                    5.8.1.2 Canada
           5.8.2 EUROPE
           5.8.3 ASIA PACIFIC
                    5.8.3.1 China
                                TABLE 9 CHINA: CLASSIFICATION OF MEDICAL DEVICES
                    5.8.3.2 Japan
                    5.8.3.3 India
           5.8.4 LATIN AMERICA
           5.8.5 MIDDLE EAST
           5.8.6 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 10 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS: GENOMICS, MICROBIOME RESEARCH, AND METAGENOMICS
    5.9 PRICING ANALYSIS 
          TABLE 11 AVERAGE SELLING PRICE, BY SERVICE AND TYPE
           5.9.1 AVERAGE SELLING PRICE TREND ANALYSIS
    5.10 KEY CONFERENCES AND EVENTS IN 2023–2024 
           TABLE 12 MICROBIOME SEQUENCING/METAGENOMIC SEQUENCING/NGS CONFERENCES, 2023–2024
    5.11 KEY STAKEHOLDERS AND BUYING CRITERIA 
           FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SEQUENCING SERVICES
           FIGURE 24 CRITERIA FOR OUTSOURCING SEQUENCING SERVICES
 
6 MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE (Page No. - 73)
    6.1 INTRODUCTION 
          TABLE 13 MARKET, BY SERVICE, 2021–2028 (USD MILLION)
    6.2 SAMPLE PREPARATION 
           6.2.1 NEED FOR SPECIFIC SAMPLE PREPARATION PROTOCOLS BASED ON SAMPLE TYPE TO DRIVE GROWTH
                    TABLE 14 MARKET FOR SAMPLE PREPARATION, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 15 NORTH AMERICA: MARKET FOR SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 16 EUROPE: MARKET FOR SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 17 ASIA PACIFIC: MARKET FOR SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 18 LATIN AMERICA: MARKET FOR SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)
    6.3 SEQUENCING AND LIBRARY PREPARATION 
           6.3.1 SEQUENCING AND LIBRARY PREPARATION SERVICES TO DOMINATE MARKET DURING FORECAST PERIOD
                    TABLE 19 MARKET FOR SEQUENCING AND LIBRARY PREPARATION, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 20 NORTH AMERICA: MARKET FOR SEQUENCING AND LIBRARY PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 21 EUROPE: MARKET FOR SEQUENCING AND LIBRARY PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 22 ASIA PACIFIC: MARKET FOR SEQUENCING AND LIBRARY PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 23 LATIN AMERICA: MARKET FOR SEQUENCING AND LIBRARY PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)
    6.4 DATA ANALYSIS 
           6.4.1 DEVELOPMENT OF ADVANCED BIOINFORMATICS SOLUTIONS TO DRIVE GROWTH
                    TABLE 24 MARKET FOR DATA ANALYSIS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 25 NORTH AMERICA: MARKET FOR DATA ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 26 EUROPE: MARKET FOR DATA ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 27 ASIA PACIFIC: MARKET FOR DATA ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 28 LATIN AMERICA: MARKET FOR DATA ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION)
 
7 MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE (Page No. - 81)
    7.1 INTRODUCTION 
          TABLE 29 MARKET, BY TYPE, 2021–2028 (USD MILLION)
    7.2 AMPLICON SEQUENCING 
           7.2.1 HIGH ACCURACY OF 16S AMPLICON SEQUENCING TO DRIVE ADOPTION
                    TABLE 30 AMPLICON SEQUENCING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 31 NORTH AMERICA: AMPLICON SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 32 EUROPE: AMPLICON SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 33 ASIA PACIFIC: AMPLICON SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 34 LATIN AMERICA: AMPLICON SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    7.3 WHOLE-GENOME SEQUENCING 
           7.3.1 ACCURATE REFERENCE GENOMES GENERATED FOR MICROBIAL IDENTIFICATION TO BOOST MARKET
                    TABLE 35 WHOLE-GENOME SEQUENCING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 36 NORTH AMERICA: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 37 EUROPE: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 38 ASIA PACIFIC: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 39 LATIN AMERICA: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    7.4 SHOTGUN SEQUENCING 
           7.4.1 ADVANCEMENTS IN DATA ANALYSIS SOLUTIONS TO SUPPORT ADOPTION
                    TABLE 40 SHOTGUN SEQUENCING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 41 NORTH AMERICA: SHOTGUN SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 42 EUROPE: SHOTGUN SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 43 ASIA PACIFIC: SHOTGUN SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 44 LATIN AMERICA: SHOTGUN SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    7.5 OTHER TYPES 
          TABLE 45 OTHER SEQUENCING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
          TABLE 46 NORTH AMERICA: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 47 EUROPE: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 48 ASIA PACIFIC: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 49 LATIN AMERICA: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
 
8 MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY (Page No. - 91)
    8.1 INTRODUCTION 
          TABLE 50 MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
    8.2 SEQUENCING BY SYNTHESIS (SBS) 
           8.2.1 SBS TECHNOLOGY ENABLES HIGHEST PRODUCTION OF BASE PAIRS IN SHORT TIME
                    TABLE 51 MARKET FOR SBS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 52 NORTH AMERICA: MARKET FOR SBS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 53 EUROPE: MARKET FOR SBS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 54 ASIA PACIFIC: MARKET FOR SBS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 55 LATIN AMERICA: MARKET FOR SBS, BY COUNTRY, 2021–2028 (USD MILLION)
    8.3 SEQUENCING BY LIGATION (SBL) 
           8.3.1 INCREASING DEMAND FOR SBL IN FOOD MICROBIOME RESEARCH TO BOOST GROWTH
                    TABLE 56 MARKET FOR SBL, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 57 NORTH AMERICA: MARKET FOR SBL, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 58 EUROPE: MARKET FOR SBL, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 59 ASIA PACIFIC: MARKET FOR SBL, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 60 LATIN AMERICA: MARKET FOR SBL, BY COUNTRY, 2021–2028 (USD MILLION)
    8.4 NANOPORE SEQUENCING 
           8.4.1 ONLY SEQUENCING TECHNOLOGY WITH DIRECT RNA SEQUENCING CAPABILITIES
                    TABLE 61 MARKET FOR NANOPORE SEQUENCING, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 62 NORTH AMERICA: MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 63 EUROPE: MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 64 ASIA PACIFIC: MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 65 LATIN AMERICA: MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2021–2028 (USD MILLION)
    8.5 OTHER TECHNOLOGIES 
          TABLE 66 MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2021–2028 (USD MILLION)
          TABLE 67 NORTH AMERICA: MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 68 EUROPE: MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 69 ASIA PACIFIC: MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 70 LATIN AMERICA: MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
 
9 MICROBIOME SEQUENCING SERVICES MARKET, BY END USER (Page No. - 101)
    9.1 INTRODUCTION 
          TABLE 71 MARKET, BY END USER, 2021–2028 (USD MILLION)
    9.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 
           9.2.1 ROBUST FUNDING FOR MICROBIOME-BASED THERAPEUTICS TO DRIVE MARKET
                        TABLE 72 MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 73 NORTH AMERICA: MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 74 EUROPE: MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 75 ASIA PACIFIC: MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 76 LATIN AMERICA: MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
    9.3 ACADEMIC AND RESEARCH INSTITUTES 
           9.3.1 EXPANDING APPLICATIONS OF MICROBIOME RESEARCH TO DRIVE GROWTH
                        TABLE 77 MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 78 NORTH AMERICA: MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 79 EUROPE: MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 80 ASIA PACIFIC: MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 81 LATIN AMERICA: MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
    9.4 OTHER END USERS 
          TABLE 82 MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)
          TABLE 83 NORTH AMERICA: MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 84 EUROPE: MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 85 ASIA PACIFIC: MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 86 LATIN AMERICA: MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
 
10 MICROBIOME SEQUENCING SERVICES MARKET, BY REGION (Page No. - 110)
     10.1 INTRODUCTION 
             FIGURE 25 MARKET, BY REGION, 2023 VS. 2028 (USD MILLION)
             TABLE 87 MARKET, BY REGION, 2021–2028 (USD MILLION)
     10.2 NORTH AMERICA 
             FIGURE 26 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET SNAPSHOT
             TABLE 88 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 89 NORTH AMERICA: MARKET, BY SERVICE, 2021–2028 (USD MILLION)
             TABLE 90 NORTH AMERICA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 91 NORTH AMERICA: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
             TABLE 92 NORTH AMERICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.2.1 US
                        10.2.1.1 Increasing awareness of microbiome research to drive growth
                                      TABLE 93 US: MARKET, BY SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 94 US: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 95 US: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 96 US: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.2.2 CANADA
                        10.2.2.1 Increasing prevalence of chronic diseases to boost microbiome research
                                      TABLE 97 CANADA: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 98 CANADA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 99 CANADA: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 100 CANADA: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.2.3 NORTH AMERICA: IMPACT OF RECESSION
     10.3 EUROPE 
             TABLE 101 EUROPE: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 102 EUROPE: MARKET, BY SERVICE, 2021–2028 (USD MILLION)
             TABLE 103 EUROPE: MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 104 EUROPE: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
             TABLE 105 EUROPE: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.1 GERMANY
                        10.3.1.1 Rapidly increasing government funding to support growth
                                      TABLE 106 GERMANY: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 107 GERMANY: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 108 GERMANY: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 109 GERMANY: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.2 UK
                        10.3.2.1 Significant government investments in genomics research to propel growth
                                      TABLE 110 UK: MARKET, BY SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 111 UK: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 112 UK: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 113 UK: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.3 FRANCE
                        10.3.3.1 Growing number of microbiome sequencing startups to propel growth
                                      TABLE 114 HUMAN MICROBIOME STARTUPS IN FRANCE
                                      TABLE 115 FRANCE: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 116 FRANCE: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 117 FRANCE: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 118 FRANCE: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.4 ITALY
                        10.3.4.1 Increasing use of microbiome services in clinical research to drive growth
                                      TABLE 119 ITALY: MARKET, BY SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 120 ITALY: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 121 ITALY: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 122 ITALY: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.5 SPAIN
                        10.3.5.1 Increasing prevalence of chronic diseases to drive market
                                      TABLE 123 SPAIN: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 124 SPAIN: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 125 SPAIN: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 126 SPAIN: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.6 REST OF EUROPE
                        TABLE 127 REST OF EUROPE: MARKET, BY SERVICE, 2021–2028 (USD MILLION)
                        TABLE 128 REST OF EUROPE: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 129 REST OF EUROPE: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                        TABLE 130 REST OF EUROPE: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.7 EUROPE: IMPACT OF RECESSION
     10.4 ASIA PACIFIC 
             FIGURE 27 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET SNAPSHOT
             TABLE 131 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 132 ASIA PACIFIC: MARKET, BY SERVICE, 2021–2028 (USD MILLION)
             TABLE 133 ASIA PACIFIC: MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 134 ASIA PACIFIC: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
             TABLE 135 ASIA PACIFIC: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.4.1 CHINA
                        10.4.1.1 Increasing investments in R&D to drive growth
                                      TABLE 136 CHINA: MARKET, BY SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 137 CHINA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 138 CHINA: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 139 CHINA: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.4.2 JAPAN
                        10.4.2.1 Significant growth in geriatric population to present opportunities for market growth
                                      TABLE 140 JAPAN: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 141 JAPAN: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 142 JAPAN: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 143 JAPAN: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.4.3 INDIA
                        10.4.3.1 Increasing prevalence of chronic diseases to support growth
                                      TABLE 144 INDIA: MARKET, BY SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 145 INDIA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 146 INDIA: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 147 INDIA: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.4.4 REST OF ASIA PACIFIC
                        TABLE 148 REST OF ASIA PACIFIC: MARKET, BY SERVICE, 2021–2028 (USD MILLION)
                        TABLE 149 REST OF ASIA PACIFIC: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 150 REST OF ASIA PACIFIC: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                        TABLE 151 REST OF ASIA PACIFIC: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.4.5 ASIA PACIFIC: IMPACT OF RECESSION
     10.5 LATIN AMERICA 
             TABLE 152 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 153 LATIN AMERICA: MARKET, BY SERVICE, 2021–2028 (USD MILLION)
             TABLE 154 LATIN AMERICA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 155 LATIN AMERICA: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
             TABLE 156 LATIN AMERICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.5.1 BRAZIL
                        10.5.1.1 Growing adoption of next-generation sequencing technologies to propel growth
                                      TABLE 157 BRAZIL: MARKET, BY SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 158 BRAZIL: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 159 BRAZIL: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 160 BRAZIL: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.5.2 REST OF LATIN AMERICA
                        TABLE 161 REST OF LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION)
                        TABLE 162 REST OF LATIN AMERICA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 163 REST OF LATIN AMERICA: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                        TABLE 164 REST OF LATIN AMERICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.5.3 LATIN AMERICA: IMPACT OF RECESSION
     10.6 MIDDLE EAST & AFRICA 
             TABLE 165 MIDDLE EAST & AFRICA: MARKET, BY SERVICE, 2021–2028 (USD MILLION)
             TABLE 166 MIDDLE EAST & AFRICA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 167 MIDDLE EAST & AFRICA: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
             TABLE 168 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.6.1 MIDDLE EAST & AFRICA: IMPACT OF RECESSION
 
11 COMPETITIVE LANDSCAPE (Page No. - 155)
     11.1 OVERVIEW 
     11.2 STRATEGIES ADOPTED BY KEY PLAYERS 
             FIGURE 28 STRATEGIES ADOPTED BY KEY PLAYERS IN MICROBIOME SEQUENCING SERVICES MARKET, 2020–2023
     11.3 MARKET SHARE ANALYSIS 
             FIGURE 29 MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022
             TABLE 169 MARKET: DEGREE OF COMPETITION
     11.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 
             FIGURE 30 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN MARKET, 2020–2022
     11.5 COMPANY EVALUATION QUADRANT 
             11.5.1 STARS
             11.5.2 EMERGING LEADERS
             11.5.3 PERVASIVE PLAYERS
             11.5.4 PARTICIPANTS
                        FIGURE 31 MARKET: COMPANY EVALUATION QUADRANT, 2022
     11.6 COMPETITIVE SCENARIO 
             TABLE 170 SERVICE LAUNCHES
             TABLE 171 DEALS
 
12 COMPANY PROFILES (Page No. - 163)
     12.1 KEY PLAYERS 
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
             12.1.1 CHARLES RIVER LABORATORIES
                        TABLE 172 CHARLES RIVER LABORATORIES: BUSINESS OVERVIEW
                        FIGURE 32 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2022)
             12.1.2 EUROFINS SCIENTIFIC
                        TABLE 173 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW
                        FIGURE 33 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2022)
             12.1.3 BGI GROUP
                        TABLE 174 BGI GROUP: BUSINESS OVERVIEW
             12.1.4 COSMOSID
                        TABLE 175 COSMOSID: BUSINESS OVERVIEW
             12.1.5 MICROBA
                        TABLE 176 MICROBA: BUSINESS OVERVIEW
             12.1.6 QIAGEN N.V.
                        TABLE 177 QIAGEN N.V.: BUSINESS OVERVIEW
                        FIGURE 34 QIAGEN N.V.: COMPANY SNAPSHOT (2022)
             12.1.7 MICROBIOME INSIGHTS
                        TABLE 178 MICROBIOME INSIGHTS: BUSINESS OVERVIEW
             12.1.8 BASECLEAR
                        TABLE 179 BASECLEAR: BUSINESS OVERVIEW
             12.1.9 CD GENOMICS
                        TABLE 180 CD GENOMICS: COMPANY OVERVIEW
             12.1.10 ZYMO RESEARCH CORPORATION
                        TABLE 181 ZYMO RESEARCH CORPORATION: COMPANY OVERVIEW
             12.1.11 ORASURE TECHNOLOGIES
                        TABLE 182 ORASURE TECHNOLOGIES: BUSINESS OVERVIEW
                        FIGURE 35 ORASURE TECHNOLOGIES: COMPANY SNAPSHOT (2022)
             12.1.12 MR DNA
                        TABLE 183 MR DNA: BUSINESS OVERVIEW
             12.1.13 EREMID GENOMIC SERVICES
                        TABLE 184 EREMID GENOMIC SERVICES: BUSINESS OVERVIEW
             12.1.14 CLINICAL-MICROBIOMICS A/S
                        TABLE 185 CLINICAL-MICROBIOMICS A/S: BUSINESS OVERVIEW
             12.1.15 NOVOGENE CO., LTD.
                        TABLE 186 NOVOGENE CO., LTD.: BUSINESS OVERVIEW
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
     12.2 OTHER PLAYERS 
             12.2.1 EZBIOME
             12.2.2 BOSTER BIOLOGICAL TECHNOLOGY
             12.2.3 ZIFO
             12.2.4 OMICS2VIEW.CONSULTING GBR
             12.2.5 MACROGEN, INC.
 
13 APPENDIX (Page No. - 194)
     13.1 DISCUSSION GUIDE 
     13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     13.3 CUSTOMIZATION OPTIONS 
     13.4 RELATED REPORTS 
     13.5 AUTHOR DETAILS 

This study involved four major activities in estimating the current size of the microbiome sequencing services market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the microbiome sequencing services market. The secondary sources used for this study include publications from government sources National Human Genome Research Institute (NHGRI), the National Center for Biotechnology Information (NCBI), the Genomics Research and Development Initiative (GRDI), UK Research and Innovation (UKRI), Microbiome Foundation France, the Centre for Genomic Regulation (CRG) Spain, Human MetaGenome Consortium Japan (HMGJ), Microbiome Research Centre (MRC) Australia, Center of Innovation in Personalized Medicine (CIPM), Department of Biotechnology (GENOME India and Microbiome) India, South African Society for Human Genetics, Food and Drug Administration (FDA), Annual Reports, SEC Fillings, Press Releases, Investor Presentation, Expert Interviews, and MarketsandMarkets Analysis. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information.

Microbiome Sequencing Services Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the microbiome sequencing services market. These methods were also used extensively to estimate the size of various segments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Microbiome Sequencing Services Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Data Triangulation

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments. To complete the overall market engineering process and arrive at the exact statistics of each market segments, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the microbiome sequencing services industry.

Market Definition

Microbiome sequencing is applied to decode the genetic material of all the microorganisms in a given sample which may contain bacteria, viruses, or fungi. Whole-genome sequencing (WGS) and amplicon sequencing are the two key microbiome sequencing services. Sequencing-based detection of microorganisms exhibits different advantages over traditional approaches, some of which are mentioned below:

  • Detection of anaerobic bacteria
  • More cost-effective microbiome characterization of multiplex microbial samples
  • Identification of non-cultivable bacteria
  • Estimate the relative abundance of microbes in a sample
  • Profile hundreds of microorganisms in a single analysis
  • Examine complex microbiomes and microbiota communities

The microbiome sequencing services market comprises services employed for sample preparation, sequencing, library preparation, and data analysis suitable for different samples, including human microbiome samples and environmental samples.

Key Stakeholders

  • Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Microbiome Sequencing Service Providers
  • Metagenomic Sequencing Service Providers
  • NGS Service Providers
  • Venture Capitalists and Investors
  • Contract Research Organizations
  • Government Associations
  • Healthcare Associations/Institutes
  • Business Research and Consulting Service Providers

Report Objectives

  • To define, describe, and forecast the global microbiome sequencing services market based on service, type, technology, end user, and region
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, challenges, and opportunities)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and provide details of
    the competitive landscape for market leaders operating in the market
  • To forecast the revenue of the market with respect to five regional segments—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile the key market players and comprehensively analyze their service portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as services launches, expansions, agreements, collaborations, partnerships, and acquisitions in the market
  • Micromarkets are the further segments and subsegments of the market.
  • Core competencies of companies are captured in terms of the key developments, market shares, and key strategies adopted to sustain their positions in the market.

Available Customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

  • Company Information: Detailed analysis and profiling of additional market players (up to five)
  • Geographic Analysis:  Further breakdown of the RoE microbiome sequencing services market, by country. Further breakdown of the RoAPAC microbiome sequencing services market, by country. Further breakdown of the RoLATAM and MEA microbiome sequencing services markets, by country.
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
BT 5306
Published ON
May, 2023
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Microbiome Sequencing Services Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback